The following data can be documented:~physical examination and vital parameters (e.g. age, weight)~comorbidities (e.g. diabetes mellitus, cardiovascular disease)~comedication (treatment of comorbidities related to NAFLD)~laboratory values (e.g. liver function tests, creatinine)~genetic variants (e.g. PNPLA3)~liver diagnostics (e.g. histological findings, sonographic findings)~lifestyle (alcohol consumption, physical activity)~health related quality of life (SF-36 questionnaire)
Characterization of patients with non-alcoholic fatty liver disease (NAFLD)~The German NAFLD-Registry (Deutsches NAFLD-Register) a project of the German Liver Foundation (Deutsche Leberstiftung), managed by Leberstiftungs-GmbH Deutschland.~The German NAFLD-Registry is financially supported by Gilead Sciences GmbH.